Non-viral Opportunistic Infections in New Users of TNF Inhibitor Therapy: Results of the SAfety Assessment of Biologic ThERapy (SABER) Study

OBJECTIVES: To determine among patients with autoimmune diseases in the United States whether the risk of non-viral opportunistic infections (OIs) was increased among new users of tumor necrosis factor-alpha inhibitors (TNFI), when compared to users of non-biologic agents used for active disease. ME...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Rheum Dis
Glavni autori: Baddley, John W., Winthrop, Kevin L., Chen, Lang, Liu, Liyan, Grijalva, Carlos G, Delzell, Elizabeth, Beukelman, Timothy, Patkar, Nivedita M., Xie, Fenglong, Saag, Kenneth G., Herrinton, Lisa J., Solomon, Daniel H., Lewis, James D., Curtis, Jeffrey R.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4273901/
https://ncbi.nlm.nih.gov/pubmed/23852763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-203407
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items